iQone Healthcare Group

iQone Healthcare Group, founded in 2015 and headquartered in Versoix (Greater Basel), Switzerland, is a commercial-stage company specializing in the distribution and market access of biosimilar and specialty medicines. Operating as a subsidiary of the South Korean biopharmaceutical giant Celltrion, iQone leverages deep local expertise and a trusted network to provide a full suite of services including logistics, inventory management, and professional support to the Swiss healthcare system. The company's core value proposition is reducing healthcare costs while ensuring reliable access to advanced therapies across multiple therapeutic areas. Its business model is built on strategic partnerships with manufacturers, hospitals, and distributors, positioning it as a key facilitator in the Swiss biosimilars landscape.

Integrated commercial, logistics, and market access service platform for the Swiss pharmaceutical market, featuring local inventory, next-day delivery, cold chain management, regulatory navigation, and tailored customer support.

iQone competes with other distributors and the commercial arms of originator biologic companies and other biosimilar manufacturers (e.g., Sandoz, Pfizer, Biogen) in the Swiss market. Its key differentiator is its deep, specialized focus on biosimilars, its agility as a local partner, and the full backing of Celltrion's manufacturing scale and pipeline.